Evanston-Northwestern Study Proves Effectiveness of MRSA Screening to Reduce Hospital ...(erland hospital was seriously flawed ac...),Health

Date:3/18/2008

erland hospital, "was seriously flawed," according to McCaughey, "rendering its findings insignificant." In that previous study, many patients were not tested until they had been in the hospital twelve hours, and test results were delayed an average of 22.5 hours after that --- a 34.5 hour delay overall. In fact, 41% of patients had already had their surgeries, before their test results were known. Consequently, the precautions, including isolation, that are supposed to be taken in response to an MRSA positive result, were not taken. The delay allowed the germ to spread to other patients.

"The evidence is overwhelming that hospitals cannot effectively prevent the spread of MRSA bacteria if they don't know which patients carry these germs," says McCaughey. "Screening saves lives. The federal Centers for Disease Control and Prevention should call on all hospitals to screen incoming patients for MRSA."

'/>"/>

SOURCE Committee to Reduce Infection Deaths Copyright©2008 PR Newswire. All rights reserved

2 GOOD

Page: 1 2
Related medicine news :

1. MTM Study Reports Improved Quality and Economic Outcomes Using Medication Management Systems Assurance Pharmaceutical Care System(TM)
2. New Healthcare Study Outlines Strategies to Increase Adoption of Home Health Monitoring Technologies
3. Neighborhoods play key role in how much people exercise, study says
4. Study Analyzed Long-Term SYMBICORT(R) Use in Children With Persistent Asthma
5. Cancer detected earlier, faster, with new medical imaging, Stanford study finds
6. Study Finds Potential Cause of Age-Related Macular Degeneration
7. New Study: Pycnogenol(R) Improves Memory in Elderly
8. Researchers study new drug and indications for heated chemotherapy treatment
9. Scripps research team wins $4M grant to study effects of chronic marijuana use
10. Meditation impacts blood pressure, study shows
11. Mayo Clinic study shows Parkinsons disease drug might work in cancer patients